CURN (CURN) Stock Price & Analysis
CURN (CURN) rose 8.99% to USD 19.52 as of June 11, 2026 at 20:57 UTC, according to Nexqual real-time market data.
CURN last closed at USD 17.91; the session ranged USD 19.3–19.53 on volume of 10,000 shares. Market capitalization is $116.81M, with a 52-week range of USD 13.86–21.3 (OQX). Source: Nexqual, June 11, 2026 at 20:57 UTC.
Key Statistics (as of June 11, 2026 at 20:57 UTC)
| Price | USD 19.52 |
|---|---|
| Change | ▲ 8.99% (up) |
| Previous Close | USD 17.91 |
| Open | USD 19.5 |
| Day Range | USD 19.3 – 19.53 |
| 52-Week Range | USD 13.86 – 21.3 |
| Volume | 10,000 shares |
| Market Cap | $116.81M |
| Exchange | OQX |
Technical Analysis (CURN)
Nexqual's technical model rates CURN "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of June 11, 2026 at 20:57 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.71 (overbought) |
| vs SMA50 | Above (USD 18.01) |
| MACD | 0.14 (positive) |
Analyst Ratings (CURN)
Wall Street analysts rate CURN "None", per Nexqual as of June 11, 2026 at 20:57 UTC.
| Consensus Rating | None |
|---|
Earnings (CURN)
| Next Earnings Date | 2026-09-09 |
|---|---|
| Revenue Estimate | $15.60M |
Source: Nexqual, June 11, 2026 at 20:57 UTC.
Financials & Fundamentals (CURN)
| Total Revenue | $74.54M |
|---|---|
| Revenue Growth (YoY) | +13.40% |
| Gross Margin | +64.43% |
| Operating Margin | +19.54% |
| Profit Margin | +6.54% |
| ROE | +16.59% |
| Debt / Equity | 7.27 |
| Current Ratio | 3.07 |
| Total Cash | $109.87M |
| Total Debt | $6.20M |
| Free Cash Flow | $31.71M |
Source: Nexqual, June 11, 2026 at 20:57 UTC.
Financial Health Score (CURN)
Nexqual rates CURN's overall financial health "Solid" across five dimensions, as of June 11, 2026 at 20:57 UTC.
| Growth | Critical — Revenue -15% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 64%, operating 20% |
| Balance Sheet | Strong — $110M cash vs $6M debt, net cash position |
| Cash Flow | Strong — FCF $32M, 44% margin |
| Efficiency | Solid — ROE 17%, ROA 9.6% |
Ownership (CURN)
| Insider Ownership | +41.14% |
|---|---|
| Institutional Ownership | +10.46% |
| Shares Outstanding | 5.98M |
| Float | 2.79M |
Source: Nexqual, June 11, 2026 at 20:57 UTC.
Leadership (CURN)
CURN is led by Randolph W. Pinna (age 56), CEO, President & Director, per Nexqual as of June 11, 2026 at 20:57 UTC.
| CEO, President & Director | Randolph W. Pinna (age 56) |
|---|---|
| Group Chief Financial Officer | Gerhard S. Barnard C.M.A. |
| Vice President of Sales | Christopher Johnson |
| Vice President of Financial Institutions | Ian Zarac |
| Senior Vice President of Human Resources | Khatuna Bezhitashvili CAMS, SHRM-SCP |
Major Backers & Investors (CURN)
Notable institutional backers of CURN include Mink Brook Asset Management LLC , according to Nexqual as of June 11, 2026 at 20:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Mink Brook Asset Management LLC | 10.02% |
Source: Nexqual, June 11, 2026 at 20:57 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CYAN | Cyanotech Corp. | USD 0.39 | ▼ 11.36% |
| AVSR | AVISTAR COMMUNICATIONS CORP | USD 0 | ▲ 0% |
| VASO | Vaso Corporation | USD 0.19 | ▲ 0% |
| ULGX | Urologix, Inc. | USD 0 | ▲ 0% |
| CWBC | Community West Bancshares | USD 25.45 | ▲ 0.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 20:57 UTC. This page is informational and not investment advice.